Phenotypes of organ involvement in sarcoidosisJonas C. Schupp, Yvonne Kendrick, Annegret Fischer et al.|European Respiratory Journal|2018Cited by 245
Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosisMartina Korfei, Andreas Günther|PLoS ONE|2018Cited by 57
Externalized histones fuel pulmonary fibrosis via a platelet-macrophage circuit of TGFβ1 and IL-27Dennis Riehl, Markus Bosmann, Arjun Sharma et al.|Proceedings of the National Academy of Sciences|2023Cited by 31
Defective BACH1/HO-1 regulatory circuits in cystic fibrosis bronchial epithelial cellsShashi Chillappagari, Andreas Günther|Journal of Cystic Fibrosis|2020Cited by 18
Preclinical concept studies showing advantage of an inhaled anti-CTGF/CCN2 protein for pulmonary fibrosis treatmentVanessa Neiens, Marina Pavlidou, Eva-Maria Hansbauer et al.|Nature Communications|2025Cited by 13